Professional Experience

Ms. Ingargiola provides strategic and regulatory advice, policy analysis and project support to pharmaceutical and biotechnology companies, healthcare providers and other healthcare clients on Medicare regulatory and reimbursement, health information technology and other issues.

Prior to joining Manatt Health Solutions, Ms. Ingargiola worked for Amylin Pharmaceuticals, a biotechnology company located in San Diego, California, where she was Associate Director for Public Policy and a founding member of the company’s Government Affairs Department. While at Amylin, Ms. Ingargiola served as the company’s lead advisor on Medicare Part D and provided strategic policy advice on issues ranging from clinical trial information disclosure to sales and marketing restrictions. Before joining Amylin in 2004, she held positions in the Public Policy and U.S. Human Health Public Affairs Departments of pharmaceutical industry leader Merck and Company, Inc. Ms. Ingargiola has also worked in both houses of Congress, including positions with the offices of U.S. Senator Robert G. Torricelli (D-NJ) and U.S. Representative Anna G. Eshoo (D-14-CA) of the House Energy and Commerce Committee. She began her career as an intern in the Clinton White House.

Education

Georgetown University, M.A., Communication, Culture & Technology, magna cum laude, 2002.

The Richard Stockton College of New Jersey, B.A., Political Science, summa cum laude, 2000.

Memberships & Activities

Member, Young Leadership Network, hosted by the American League of Lobbyists (ALL).

Member, California Elected Women’s Association.

Past Delegate, Atlantic County, New Jersey Democratic Convention.

Member, Communication, Culture & Technology Alumni Council, Georgetown University.

Publications

Co-Author, “E-Prescribing Mandate May Be Included in Medicare Package,” Healthcare Law Newsletter, Manatt, Phelps & Phillips, LLP, May 23, 2008.

Co-Author, “E-Prescribing’s Dirty Little Secret – Secret Status Update on the DEA Controlled Substances Ban,” Healthcare Law Newsletter, Manatt, Phelps & Phillips, LLP, May 5, 2008.

Summary, “Model Guidelines and Formulary Key Drug Types Version 4.0,” U.S. Pharmacopeia, February 2008.

“Key Elements of DRAFT 2009 Medicate:  Advantage (MA), Medicare Advantage-Prescription Drug (MA-PD), Cost-Based Plan, and Prescription Drug Plan (PDP) Sponsors Call Letter (Part D Section,” Manatt Health Solutions Alert, January 17, 2008.

Contributor, “E-Prescribing...Has Its Time Finally Come?: E-Prescribing Heating Up at the National and State Levels,” Healthcare Law Newsletter, Manatt, Phelps & Phillips, LLP, December 2007.

Co-Author, “Private Medicare Drug Plans:  High Expenses and Low Rebates Increase the Costs of Medicare Drug Coverage,” Life Sciences Practice Group E-mail Alert, American Health Lawyers Association, October 16, 2007.

Co-Author, “Vaccine Administration and Access Update:  Beneficiaries to Receive Greater Access to Vaccines in 2008,” Life Sciences Law & Industry Report 1(13), September 14, 2007.

Contributor, “CHI Hosts Annual Healthcare Policy Forum:  The Information Technology-Enabled Movement to Achieve Value-Driven Healthcare,” California Healthcare Institute White Paper, August 2, 2007.

Co-Author, “Part D Formularies:  The Ongoing Battleground between Access and Cost,” Chapter in Health Law Handbook, Thompson/West, May 2007.

Co-Author, “CMS Issues 2008 Part D Vaccine Guidance Summary,” Life Sciences Practice Group E-mail Alert, American Health Lawyers Association, May 15, 2007.

Co-Aauthor, “Summary of Baucus Proposed Legislation to Strike the Non-Interference Clause,” American Health Lawyers Association Practice Group E-mail Alert, April 11, 2007.

Co-Author, “New Developments in Part D Vaccine Administration and Access,” BNA's Health Plan & Provider Report , January 10, 2007.

“Governor’s Healthcare Focus Confirmed in State of the State Address and Reform Speech,” Healthcare Law Newsletter, Manatt, Phelps & Phillips, LLP, January 2007.

Author, “Healthcare Headed for the Spotlight in California; Schwarzenegger Focusing on Coverage and Affordability,” Healthcare Law Newsletter, Manatt, Phelps & Phillips, LLP, December 2006.

Contributor, “The Power to Help:  U.S. Businesses Creating a Better Tomorrow,” a report to the President from the President's Export Council on U.S. Corporate Stewardship Around the World, Fall 2004.

Honors & Awards

Amylin Special Recognition Award, February 2006.

Merck Award of Excellence in publishing FOSAMAX 10-year data, April 2004.